ArticleInternational journal of molecular sciencesPublished
FDA-Approved Drug Repurposing as p53 Mutants Rescue Candidates Using Structure-Based Virtual Screening and Molecular Simulations
Regional connection
Listed An author affiliation on the Europe PMC record names Lankenau Institute for Medical Research, with Main Line Health linked by the institution reference. Affiliation source
- Institutions
- Lankenau Institute for Medical Research, Main Line Health
Publication record
- Type
- Article
- Venue
- International journal of molecular sciences
- Published
- Topic
- Disease research
- Subject terms
- Humans; Ligands; Drug Approval; Protein Binding; Mutation; United States Food and Drug Administration; United States; Tumor Suppressor Protein p53; Molecular Dynamics Simulation; Drug Repositioning; Molecular Docking Simulation; Allosteric modulation
- PubMed ID
- 42589334
- PubMed Central ID
- PMC13466752
- Open access
- Yes, open
- Added to directory
- Source checked